News – Page 912 – Endpoints News

SIGN UP

Eli Lilly shutters the last PhIII sola study, certain of failure

7 years ago

Pfizer prunes three drugs from its pipeline; Astellas in-licenses ear drug

7 years ago

Trump scolds pharma execs, demanding lower prices, more US manufacturing while promising to slash FDA regs

7 years ago

Tenax endures (another) clinical catastrophe as its PhIII flops, shares blitzed

7 years ago

On a deal spree, Takeda grabs Japanese cabo rights in $145M pact with Exelixis

7 years ago

Another top Genentech exec gets poached, this time taking the helm at CAR-T player Bellicum

7 years ago

Big Pharma CEOs get a face-to-face with Trump and a shot at a negotiated cease fire

7 years ago

After a PhII catastrophe wiped out a billion dollars in market cap, Seres is looking for a do-over

7 years ago

uniQure wins a BTD for hemophilia B therapy; Allergan scores sNDA for Avycaz

7 years ago

Microcap biotech Ocera craters on a PhIIb failure for hepatic encephalopathy

7 years ago

FibroGen, AstraZeneca ready China application as anemia drug scores in two pivotal studies

7 years ago

Incyte grabs control of a cancer drug from Calithera’s pipeline for $53M up front

7 years ago

Novo Nordisk shrugs off Brexit, unveils $144M plan for a diabetes research center at Oxford

7 years ago

Biotech execs slam Trump’s travel ban, counting the high cost to a global industry

7 years ago

Regulus ordered to remain in limbo as FDA refuses to lift hold, demanding more data on lead drug

7 years ago

Novan’s shares in meltdown following "discordant" PhIII studies of a new acne drug

7 years ago

Ouch: Eli Lilly is walking away from Adocia deal and its ultra-fast insulin — for the second time

7 years ago

Highland who? Biotech gets a $200M war chest to crack the US ADHD market

7 years ago

Jounce’s Cinderella story now includes a $102M IPO chapter

7 years ago

Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round

7 years ago

M&A is off to a hot start in 2017; Too bad we can't say the same for gender parity

7 years ago

Singapore investors at Temasek grab an $800M stake in Google’s Verily

7 years ago

Venrock stocks up on $450M Fund 8 as it prepares a new string of biotech deals

7 years ago

Endo axes R&D staff in restructuring; China biotech Connect raises $20 million

7 years ago

First page Previous page 909 910 911912913 914 915 Next page Last page